In September 2022, 47.5% of patients classed as R1 were waiting within their target review date against a target of 95%.
Ym Medi 2022, roedd 47.5% o gleifion a ddosbarthwyd yn R1 yn aros o fewn eu dyddiad adolygu targed yn erbyn targed o 95%.